Category Archives: Life Extension

The Veslefrikk field in the North Sea.

(Photo: yvind Hagen / courtesy Equinor)

Offshore staff

STAVANGER, Norway Equinor and its partners will end production from the Veslefrikk field in the Norwegian Sea in spring 2022.

Operations started in 1989 through Norways first floating production platform, and the facilities have since produced over 400 MMboe.

Investments to date total around NOK20 billion ($2.36 billion), and the fields productive life has been extended several times: it was originally expected to cease production in 2009.

Veslefrikk B is a semisubmersible production platform is connected to the fixed Veslefrikk A wellhead platform (converted from the drilling rig West Vision).

In 2002 the field also began processing from the Huldra field (since decommissioned) with a shared control room and crew.

Equinor operates Veslefrikk from its center in Sandsli outside Bergen, which also oversees operations at the Oseberg area.

In the fall of 2020, the company submitted its decommissioning plan to the Norwegian authorities. Its new Field Life Extension (FLX) business area has responsibility for implementing decommissioning projects on the Norwegian continental shelf.

Before Veslefrikk B can be towed to shore for dismantling in the fall of 2022, its topside systems must be shut down and cleaned, and oil and gas export pipelines cleaned and disconnected.

Over the years 74 wells have been drilled on the field. Archer started plugging wells from Veslefrikk B last month, with Baker and Ardyne supplying most other drilling and well services: a total of 24 wells will be plugged.

Veslefrikk A should be removed in 2025/26.

Before mid-2021 Equinor expects to award contracts for removal and dismantling of Veslefrikk A; dismantling and recycling of Veslefrikk B; and work on the seafloor associated with export pipeline cleaning and disconnection.

Further contracts will follow for the planning, management, and implementation of the towing of Veslefrikk B to shore.

Other partners in the license are Petoro, Repsol Norge, and Wintershall Dea Norge.

02/22/2021

Excerpt from:

North Sea Veslefrikk field to cease operations - Offshore Oil and Gas Magazine

Jinxia Li,1 Yiping Wang,2 Weiyang Jin,3 Li Shen4

1College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, Peoples Republic of China; 2Key Laboratory of Digestive Pathophysiology of Zhejiang Province, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, Peoples Republic of China; 3School of Life and Environmental Science, Hangzhou Normal University, Hangzhou, 311121, Peoples Republic of China; 4Institute of Basic Theory of TCM, China Academy of Chinese Medical Sciences, Beijing, 100700, Peoples Republic of China

Correspondence: Li ShenInstitute of Basic Theory of TCM, China Academy of Chinese Medical Sciences, Beijing, 100700, Peoples Republic of ChinaTel +86-158-5825-6870Email shenli1116@126.com

Objective: To observe the efficacy of Actinidia eriantha polysaccharide (AEPS) combined with PD1 antibody therapy in colorectal cancerxenograft mice.Methods: CT26 cells were inoculated into 80 C57BL/6 mice to establish the colorectal cancer xenograftmouse model. Mice were divided evenly into a model group, AEPS group, anti-PD1 group, and combined group. AEPS 5mL/kgday was given orally and 10 mg/kg anti-PD1 injected intravenously for 28 days. Tumor growth and mouse survival were observed. Tumor-cell proliferation and metastasis markers Ki67, N-cadherin, KLF4, and Oct4 were detected with immunochemistry and Western blotting, T-cell infiltration in spleens and tumors was detected with MTT and flow cytometry. IFN and TNF were detected with ELISA.Results: Tumor growth was significantly retarded and survival prolonged in the AEPS, anti-PD1, and combined groups. Ki67 expression decreased in the anti-PD1 and combined groups, and N-cadherin, KLF4, and Oct4 expression decreased in the AEPS and combined groups. IFN and TNF levels, T-cell infiltration in spleen, and tumor all increased distinctively in the AEPS and combined groups. The combined group showed better antitumor effects and life-extension effect than the other two groups.Conclusion: AEPS and PD1 antibody-combination therapy can suppresses tumor growth and prolong survival of colorectal cancerxenograft mice by regulating immunofunction, and the combined therapy showed better therapeutic efficacy than the single treatment.

Keywords: colorectal cancer, PD1 antibody, Actinidia eriantha polysaccharide, combined therapy

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Read more here:

Actinidia eriantha Polysaccharide and PD1-Antibody Combination Therapy | OTT - Dove Medical Press

LOS ANGELES, United States: QY Research has recently published a market research report titled, Global Allicin Supplement Sales Market Report 2021. Analysts have used primary and secondary research methodologies to determine the path of the market. The data includes historic and forecast values for a well-rounded understanding. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Allicin Supplement market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Allicin Supplement market.

TThis report includes assessment of various drivers, government policies, technological innovations, upcoming technologies, opportunities, market risks, restrains, market barriers, challenges, trends, competitive landscape, and segments which gives an exact picture of the growth of the global Allicin Supplement market.

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Allicin Supplement market.

Key questions answered in the report:

TOC

1 Allicin Supplement Market Overview1.1 Allicin Supplement Product Scope1.2 Allicin Supplement Segment by Type1.2.1 Global Allicin Supplement Sales by Type (2016 & 2021 & 2027)1.2.2 Tablets1.2.3 Capsules1.2.4 Soft Gels1.3 Allicin Supplement Segment by Application1.3.1 Global Allicin Supplement Sales Comparison by Application (2016 & 2021 & 2027)1.3.2 Supermarket/Hypermarekt1.3.3 Online Retail1.3.4 Department Store1.3.5 Drug Store1.3.6 Others1.4 Allicin Supplement Market Estimates and Forecasts (2016-2027)1.4.1 Global Allicin Supplement Market Size in Value Growth Rate (2016-2027)1.4.2 Global Allicin Supplement Market Size in Volume Growth Rate (2016-2027)1.4.3 Global Allicin Supplement Price Trends (2016-2027) 2 Allicin Supplement Estimates and Forecasts by Region2.1 Global Allicin Supplement Market Size by Region: 2016 VS 2021 VS 20272.2 Global Allicin Supplement Retrospective Market Scenario by Region (2016-2021)2.2.1 Global Allicin Supplement Sales Market Share by Region (2016-2021)2.2.2 Global Allicin Supplement Revenue Market Share by Region (2016-2021)2.3 Global Allicin Supplement Market Estimates and Forecasts by Region (2022-2027)2.3.1 Global Allicin Supplement Sales Estimates and Forecasts by Region (2022-2027)2.3.2 Global Allicin Supplement Revenue Forecast by Region (2022-2027)2.4 Geographic Market Analysis: Market Facts & Figures2.4.1 North America Allicin Supplement Estimates and Projections (2016-2027)2.4.2 Europe Allicin Supplement Estimates and Projections (2016-2027)2.4.3 China Allicin Supplement Estimates and Projections (2016-2027)2.4.4 Japan Allicin Supplement Estimates and Projections (2016-2027)2.4.5 Southeast Asia Allicin Supplement Estimates and Projections (2016-2027)2.4.6 India Allicin Supplement Estimates and Projections (2016-2027) 3 Global Allicin Supplement Competition Landscape by Players3.1 Global Top Allicin Supplement Players by Sales (2016-2021)3.2 Global Top Allicin Supplement Players by Revenue (2016-2021)3.3 Global Allicin Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Allicin Supplement as of 2020)3.4 Global Allicin Supplement Average Price by Company (2016-2021)3.5 Manufacturers Allicin Supplement Manufacturing Sites, Area Served, Product Type3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Allicin Supplement Market Size by Type4.1 Global Allicin Supplement Historic Market Review by Type (2016-2021)4.1.1 Global Allicin Supplement Sales Market Share by Type (2016-2021)4.1.2 Global Allicin Supplement Revenue Market Share by Type (2016-2021)4.1.3 Global Allicin Supplement Price by Type (2016-2021)4.2 Global Allicin Supplement Market Estimates and Forecasts by Type (2022-2027)4.2.1 Global Allicin Supplement Sales Forecast by Type (2022-2027)4.2.2 Global Allicin Supplement Revenue Forecast by Type (2022-2027)4.2.3 Global Allicin Supplement Price Forecast by Type (2022-2027) 5 Global Allicin Supplement Market Size by Application5.1 Global Allicin Supplement Historic Market Review by Application (2016-2021)5.1.1 Global Allicin Supplement Sales Market Share by Application (2016-2021)5.1.2 Global Allicin Supplement Revenue Market Share by Application (2016-2021)5.1.3 Global Allicin Supplement Price by Application (2016-2021)5.2 Global Allicin Supplement Market Estimates and Forecasts by Application (2022-2027)5.2.1 Global Allicin Supplement Sales Forecast by Application (2022-2027)5.2.2 Global Allicin Supplement Revenue Forecast by Application (2022-2027)5.2.3 Global Allicin Supplement Price Forecast by Application (2022-2027) 6 North America Allicin Supplement Market Facts & Figures6.1 North America Allicin Supplement Sales by Company6.1.1 North America Allicin Supplement Sales by Company (2016-2021)6.1.2 North America Allicin Supplement Revenue by Company (2016-2021)6.2 North America Allicin Supplement Sales Breakdown by Type6.2.1 North America Allicin Supplement Sales Breakdown by Type (2016-2021)6.2.2 North America Allicin Supplement Sales Breakdown by Type (2022-2027)6.3 North America Allicin Supplement Sales Breakdown by Application6.3.1 North America Allicin Supplement Sales Breakdown by Application (2016-2021)6.3.2 North America Allicin Supplement Sales Breakdown by Application (2022-2027) 7 Europe Allicin Supplement Market Facts & Figures7.1 Europe Allicin Supplement Sales by Company7.1.1 Europe Allicin Supplement Sales by Company (2016-2021)7.1.2 Europe Allicin Supplement Revenue by Company (2016-2021)7.2 Europe Allicin Supplement Sales Breakdown by Type7.2.1 Europe Allicin Supplement Sales Breakdown by Type (2016-2021)7.2.2 Europe Allicin Supplement Sales Breakdown by Type (2022-2027)7.3 Europe Allicin Supplement Sales Breakdown by Application7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)7.3.2 Europe 143 Sales Breakdown by Application (2022-2027) 8 China Allicin Supplement Market Facts & Figures8.1 China Allicin Supplement Sales by Company8.1.1 China Allicin Supplement Sales by Company (2016-2021)8.1.2 China Allicin Supplement Revenue by Company (2016-2021)8.2 China Allicin Supplement Sales Breakdown by Type8.2.1 China Allicin Supplement Sales Breakdown by Type (2016-2021)8.2.2 China Allicin Supplement Sales Breakdown by Type (2022-2027)8.3 China Allicin Supplement Sales Breakdown by Application8.3.1 China 312 Sales Breakdown by Application (2016-2021)8.3.2 China 312 Sales Breakdown by Application (2022-2027) 9 Japan Allicin Supplement Market Facts & Figures9.1 Japan Allicin Supplement Sales by Company9.1.1 Japan Allicin Supplement Sales by Company (2016-2021)9.1.2 Japan Allicin Supplement Revenue by Company (2016-2021)9.2 Japan Allicin Supplement Sales Breakdown by Type9.2.1 Japan Allicin Supplement Sales Breakdown by Type (2016-2021)9.2.2 Japan Allicin Supplement Sales Breakdown by Type (2022-2027)9.3 Japan Allicin Supplement Sales Breakdown by Application9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Allicin Supplement Market Facts & Figures10.1 Southeast Asia Allicin Supplement Sales by Company10.1.1 Southeast Asia Allicin Supplement Sales by Company (2016-2021)10.1.2 Southeast Asia Allicin Supplement Revenue by Company (2016-2021)10.2 Southeast Asia Allicin Supplement Sales Breakdown by Type10.2.1 Southeast Asia Allicin Supplement Sales Breakdown by Type (2016-2021)10.2.2 Southeast Asia Allicin Supplement Sales Breakdown by Type (2022-2027)10.3 Southeast Asia Allicin Supplement Sales Breakdown by Application10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Allicin Supplement Market Facts & Figures11.1 India Allicin Supplement Sales by Company11.1.1 India Allicin Supplement Sales by Company (2016-2021)11.1.2 India Allicin Supplement Revenue by Company (2016-2021)11.2 India Allicin Supplement Sales Breakdown by Type11.2.1 India Allicin Supplement Sales Breakdown by Type (2016-2021)11.2.2 India Allicin Supplement Sales Breakdown by Type (2022-2027)11.3 India Allicin Supplement Sales Breakdown by Application11.3.1 India Allicin Supplement Sales Breakdown by Application (2016-2021)11.3.2 India Allicin Supplement Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Allicin Supplement Business12.1 Nature Made12.1.1 Nature Made Corporation Information12.1.2 Nature Made Business Overview12.1.3 Nature Made Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.1.4 Nature Made Allicin Supplement Products Offered12.1.5 Nature Made Recent Development12.2 Natures Bounty12.2.1 Natures Bounty Corporation Information12.2.2 Natures Bounty Business Overview12.2.3 Natures Bounty Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.2.4 Natures Bounty Allicin Supplement Products Offered12.2.5 Natures Bounty Recent Development12.3 Allimax International12.3.1 Allimax International Corporation Information12.3.2 Allimax International Business Overview12.3.3 Allimax International Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.3.4 Allimax International Allicin Supplement Products Offered12.3.5 Allimax International Recent Development12.4 Life Extension12.4.1 Life Extension Corporation Information12.4.2 Life Extension Business Overview12.4.3 Life Extension Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.4.4 Life Extension Allicin Supplement Products Offered12.4.5 Life Extension Recent Development12.5 ZHOU Nutrition12.5.1 ZHOU Nutrition Corporation Information12.5.2 ZHOU Nutrition Business Overview12.5.3 ZHOU Nutrition Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.5.4 ZHOU Nutrition Allicin Supplement Products Offered12.5.5 ZHOU Nutrition Recent Development12.6 Swisse12.6.1 Swisse Corporation Information12.6.2 Swisse Business Overview12.6.3 Swisse Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.6.4 Swisse Allicin Supplement Products Offered12.6.5 Swisse Recent Development12.7 Healthy Options12.7.1 Healthy Options Corporation Information12.7.2 Healthy Options Business Overview12.7.3 Healthy Options Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.7.4 Healthy Options Allicin Supplement Products Offered12.7.5 Healthy Options Recent Development12.8 Now Foods12.8.1 Now Foods Corporation Information12.8.2 Now Foods Business Overview12.8.3 Now Foods Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.8.4 Now Foods Allicin Supplement Products Offered12.8.5 Now Foods Recent Development12.9 Solaray12.9.1 Solaray Corporation Information12.9.2 Solaray Business Overview12.9.3 Solaray Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.9.4 Solaray Allicin Supplement Products Offered12.9.5 Solaray Recent Development12.10 21st Century12.10.1 21st Century Corporation Information12.10.2 21st Century Business Overview12.10.3 21st Century Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.10.4 21st Century Allicin Supplement Products Offered12.10.5 21st Century Recent Development12.11 Carica12.11.1 Carica Corporation Information12.11.2 Carica Business Overview12.11.3 Carica Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.11.4 Carica Allicin Supplement Products Offered12.11.5 Carica Recent Development12.12 Dr. Willmar Schwabe12.12.1 Dr. Willmar Schwabe Corporation Information12.12.2 Dr. Willmar Schwabe Business Overview12.12.3 Dr. Willmar Schwabe Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.12.4 Dr. Willmar Schwabe Allicin Supplement Products Offered12.12.5 Dr. Willmar Schwabe Recent Development12.13 Nutra-Life12.13.1 Nutra-Life Corporation Information12.13.2 Nutra-Life Business Overview12.13.3 Nutra-Life Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.13.4 Nutra-Life Allicin Supplement Products Offered12.13.5 Nutra-Life Recent Development12.14 Blackmores12.14.1 Blackmores Corporation Information12.14.2 Blackmores Business Overview12.14.3 Blackmores Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.14.4 Blackmores Allicin Supplement Products Offered12.14.5 Blackmores Recent Development12.15 Healthy Care12.15.1 Healthy Care Corporation Information12.15.2 Healthy Care Business Overview12.15.3 Healthy Care Allicin Supplement Sales, Revenue and Gross Margin (2016-2021)12.15.4 Healthy Care Allicin Supplement Products Offered12.15.5 Healthy Care Recent Development 13 Allicin Supplement Manufacturing Cost Analysis13.1 Allicin Supplement Key Raw Materials Analysis13.1.1 Key Raw Materials13.1.2 Key Raw Materials Price Trend13.1.3 Key Suppliers of Raw Materials13.2 Proportion of Manufacturing Cost Structure13.3 Manufacturing Process Analysis of Allicin Supplement13.4 Allicin Supplement Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers14.1 Marketing Channel14.2 Allicin Supplement Distributors List14.3 Allicin Supplement Customers 15 Market Dynamics15.1 Allicin Supplement Market Trends15.2 Allicin Supplement Drivers15.3 Allicin Supplement Market Challenges15.4 Allicin Supplement Market Restraints 16 Research Findings and Conclusion 17 Appendix17.1 Research Methodology17.1.1 Methodology/Research Approach17.1.2 Data Source17.2 Author List17.3 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Originally posted here:

Allicin Supplement Market Insights, SWOT Analysis and Future Growth trend by Players Nature Made, Nature's Bounty, Allimax International, Life...

Representational image

Can anyone perceive questions and provide answers in the midst of a vivid dream? It is possible, say researchers of a recent study whose results might sound like a real-life extension of the Hollywood blockbuster Inception.

The findings of the study indicate that it is possible for people while dreaming to follow instructions, do simple math, answer yes-or-no questions, or tell the difference between different sensory stimuli.

"We found that individuals in REM sleep can interact with an experimenter and engage in real-time communication," said researcher Ken Paller from Northwestern University in the US. According to the researcher, dreamers are capable of comprehending questions, engaging in working-memory operations and producing answers.

"Most people might predict that this would not be possiblethat people would either wake up when asked a question or fail to answer and certainly not comprehend a question without misconstruing it," Paller said. But the research shows that people in dreams could respond using eye movements or by contracting facial muscles.

For the study, published in the journal Current Biology, the researchers evaluated 36 people who aimed to have a lucid dream, in which a person is aware they're dreaming. The researchers refer to it as "interactive dreaming."

The researchers said that future studies of dreaming could use these same methods to assess cognitive abilities during dreams versus wake. Outside of the laboratory, the methods could be used to help people in various ways, such as solving problems during sleep or offering nightmare sufferers novel ways to cope, the team noted.

**

The above article has been published from a wire source with minimal modifications to the headline and text.

Continue reading here:

Real-Time Communication with Dreaming Person Possible, Says Study | The Weather Channel - Articles from The Weather Channel | weather.com - The...

Two projects involving the University of Strathclyde have received funding from Scottish Enterprises Low Carbon Challenge Fund.

The Low Carbon Challenge Fund is a partnership between the Scottish Government and Scottish Enterprise with total investment of 2.79 million with 1.39 million from the European Regional Development Fund and match-funding from the projects.

The University of Strathclyde is leading one project which will help the aerospace, rail and renewables sector to address the challenges around life extension and repurposing of assets and builds on linked projects.

The university will work with companies across Scotland to support their journey from identifying opportunities to reduce waste to demonstrating the process towards a circular economy.

Dr David Butler, Reader in the Department of Design, Engineering and Manufacturing Management, said: The project provides for timely intervention and support for SMEs who wish to engage the three sectors and benefit from the opportunities arising from aircraft decommissioning and the life time extension of rail rolling stock and onshore wind turbines.

With the drive towards the Scottish Governments net-zero targets it is important that we look for environmentally sustainable routes to develop new products and services which demonstrate best green practices and encourage reuse rather than disposal at the end of the product life cycle.

A second project, led by the University of St Andrews, and partnering with Strathclyde will assist companies throughout the hydrogen supply chain from fuel cell manufacturers to energy specialists to create a strong Scottish original equipment manufacturing (OEM) base.

The project builds on wider strategic initiatives around the Scottish Governments hydrogen action plan and hydrogen policy statement.

The fund was set up last year and provided opportunities for public, third sector and academic institutions to, in turn, develop projects for SMEs to support low carbon innovation and manufacturing capabilities across Scotland.

Scottish Enterprise Chief Executive Linda Hanna said: The Low Carbon Challenge Fund is a catalyst to support economic opportunities in Scotland and nurture businesses to develop net zero products, processes and services.

I look forward to seeing these pioneering projects take shape as they have the potential to transform the way companies work whether it is reducing manufacturing waste, future-proofing transport to developing new hydrogen products.

The three successful projects will harness the expertise of public sector partnerships and engage businesses in Scotland towards the transition to a net zero nation.

The university will establish a business advice service, seminars and provide access to testing equipment in addition to supporting early stage prototyping to identify innovation opportunities.

The rest is here:

Strathclyde secures funding for low carbon SME projects - University of Strathclyde

Chandler Rome,Staff writer

Feb. 22, 2021Updated: Feb. 22, 2021 1:05p.m.

WEST PALM BEACH, Fla. Carlos Correa said there have been no talks about a long-term contract extension between his representation and the Astros.

"There's no talks right now about that. Talks are nowhere right now," Correa said. "I leave that up to my agent and the organization, but right now, there's no talks about it. I haven't heard from them since the arbitration was settled. That's where we are right now."

Last month, Correa told a team-sponsored radio show that he'd love to be "an Astro for life." He's among a star-studded group of shortstops set to enter free agency following the 2021 season.

"I'm not scared of free agency, but as I've said before and shared before, I feel like this is the team I grew up in. I feel like this is my team. I feel like I belong here. But they have to feel the same way."

Correa added "ifthe Astros want to extend me, I would like to get it done before the season starts."

Chandler Rome joined the Houston Chronicle in 2018 to cover the Astros after spending one year in Tuscaloosa covering Alabama football - during which Nick Saban asked if he attended college. He did, at LSU, where he covered the Tigers baseball team for nearly four years. He covered most of the Astros' 2015 playoff run, too, as an intern for MLB.com

View post:

Carlos Correa: Extension talks 'are nowhere right now' with Astros - Houston Chronicle

Growing emphasis on the food safety and longer shelf life has played an important role in the development of ingredients that aid in food preservation. These ingredients vary from simple water content to salt or sugar to chemicals like antioxidants and are used to prevent growth of microorganisms, thereby delaying the spoilage process. In terms of origin, food safety and shelf life extension ingredients can be synthetic or natural in nature.

Food preserving ingredients have been an integral part of kitchen aisles in the form of lemon, ginger, vinegar, spices, salt and sugar. Their traditional utilization was replaced by synthetic ingredients with increasing commercialization of the food industry in past decades. However, with the dissemination of knowledge related to harmful effects of synthetic ingredients, currently, the industry is witnessing a prominent shift toward natural ingredients for food safety and shelf life extension.

Get Brochure of the Report@https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4578

Shelf Life Extension Ingredients Market Notable Developments

Shelf Life Extension Ingredients Market Dynamics

Clean-Label Trend Fuels Synthetic to Natural Transition in Food Ingredient Landscape

Naturally sourced ingredients have gained significant traction as consumer preference for natural products continues to surge. In terms of effectiveness, natural preservatives are superior in delivering greater protection and longer shelf life. As they work with equivalent efficiency and are healthful in nature, adoption of naturally sourced ingredients is increasing consistently as compared to the synthetic options.

Natural ingredients such as antimicrobials or antioxidants have additional potential health benefits also. Well aware of the increasing consumer demand for natural food products that are without artificial ingredients, manufacturers in the food ingredient market are introducing bio-based or naturally sourced food safety ingredients.

Frozen Foods Drive Demand for Specialized Food Safety Ingredients

Ranging from salads to sauces or ready meals to rice, a plethora of food products are available in frozen forms. As the demand for fresh and frozen foods increase across the globe, food manufacturers are seeking innovative ways to introduce novel food safety ingredients to extend the shelf life of frozen foods.

Manufacturers in the food safety and shelf life extension ingredient market are introducing ingredients specific to refrigerated products. Along with providing safety, these ingredients are label friendly and help in reducing sodium content while enhancing consumers sensory experience.

Request For Discount @https://www.tmrresearch.com/sample/sample?flag=D&rep_id=4578

Shelf Life Extension Ingredients Market Regional Outlook

North America presents lucrative opportunities for the Shelf Life Extension Ingredients Market on the back of buoyancy in regions the food and beverage industry and presence of leading F&B companies.

The market is likely to witness increasing opportunities in the developing countries of Asia pacific. These countries are witnessing huge demand for frozen foods, RTD food and beverages and processed food, thereby presenting higher potential for the market in the future.

Shelf Life Extension Ingredients Market Segmentation

The Shelf Life Extension Ingredients Market is segmented into following,

Based on type, Shelf Life Extension Ingredients Market can be segmented in,

Based in function, Shelf Life Extension Ingredients Market can be segmented in,

Based on application, Shelf Life Extension Ingredients Market can be segmented in,

Get Table of Content of the Report @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=4578

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

View post:

Shelf Life Extension Ingredients Market Size, Share Production & Consumption Analysis With Forecast To 2028 The Bisouv Network - The Bisouv...

Francisco Lindor during spring training Zoom on Feb. 22 2021

With Opening Day just over a month away, the Mets and Francisco Lindor have not had any talks about a contract extension. But there is "mutual interest" in getting one done, Lindor said on Monday.

"We haven't found the time," Lindor told reporters via Zoom. "I obviously got to get to know the organization, get to know the people. And they have to get to know me. If something comes up, we'll see in the future.

"That's between my agent and Sandy (Alderson) and the rest of the staff. I'm just focused on my business and that's doing things the right way here. There's been no insistence. I think it's too early, I think. I'm not sure."

In addition to Lindor, the Mets are also open to a long-term extension with Michael Conforto, who -- like Lindor -- is set to hit free agency after the season.

And while the Mets and Lindor haven't yet had serious talks about a deal (something acting GM Zack Scott recently said would likely happen at spring training), Lindor said there is interest from both sides.

"There's mutual interest. Like I said earlier, I've never been shy about an extension," Lindor explained. "Cleveland did what they had to do. They couldn't keep me. They weren't in the position to keep me. They decided to go in a different route. I've never been shy about an extension, but everything has to make sense. It has to make sense. If it doesn't make sense, then that's just not fair."

Asked about the Opening Day deadline for an extension that he loosely put in place during his introductory news conference as a Met, Lindor said the point of the deadline is to keep the focus on the field once the regular season starts.

"The reason why I have said I don't want it to (go beyond) Opening Day is because as players we have a duty. And the duty is show up and win," he said. "It would be unfair for me and the rest of the team to have an ongoing conversation about extending -- whether it's me or other players -- and we show up on Opening Day and our mind is somewhere else and we don't focus on our duty."

Asked if the 14-year, $340 million deal Fernando Tatis Jr. recently signed with the San Diego Padres would impact him, Lindor instead focused on Tatis' achievement and mentioned that he texted to congratulate him, adding about his own future:

"I've never been scared of free agency. It's not like I got to rush to sign a deal or I can't wait for free agency. I live life on a daily basis."

See the rest here:

Francisco Lindor open to Mets extension, but talks haven't started: 'I've never been scared of free agency' - Yahoo Sports

Courant Market Research Latest 2021 Report : The Global Antioxidant Vitamin Market Research Report represents a comprehensive study on the Antioxidant Vitamin industry including current trends and status.

At an initial stage, the Antioxidant Vitamin market report offers basic information including definitions, classifications, a wide range of applications, and the Antioxidant Vitamin industry chain framework. This report also covers industry development plans and policies, product specification, Antioxidant Vitamin manufacturing process, and pricing structures. It focuses on an in-depth study of the global factors influencing the Antioxidant Vitamin market such as market revenue, product cost, utilization rate, and supply and demand analysis. Additionally, it provides information on the long-term implications of the COVID-19 virus outbreak for further understanding of growth prospects.

Request free sample report https://courant.biz/report/global-antioxidant-vitamin-market/62304/

It presents a complete overview, market shares, and market growth opportunities of the Antioxidant Vitamin by product type, application, key manufacturers, and key regions and countries.

This study considers the value of Antioxidant Vitamin and the volume generated from the sales of the following segments:

The report also presents the competitive landscape in the market and a corresponding detailed analysis of the main manufacturers in the market.

Access main content of the research https://courant.biz/report/global-antioxidant-vitamin-market/62304/

In this essential research report, data related to the top manufacturer has been included, including its price, sales, revenue, product portfolio and global market share, business segmentation and financial description. The updated study report examines the global Antioxidant Vitamin market in detail by outlining the key aspects of the market that are predicted to have a quantifiable effect on its development prospects during the forecast period 2021-2029. The survey examines the complete demand and supply chain in the world market and studies the various components. Various research tools, such as Porters Five Forces Analysis and SWOT Analysis, have been used to present an accurate understanding of this market to readers.

Finally, this report looks at the key factors influencing market growth, opportunities, challenges and risks faced by key manufacturers. It also looks at key upward trends and their impact on present and future development.

BROWSE COMPLETE REPORT AND TABLE OF CONTENTS :https://courant.biz/report/global-antioxidant-vitamin-market/62304/

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs.

Excerpt from:

Antioxidant Vitamin Market 2029 Competitive Analysis | Vibrant Health, AST R-ALA, GNC, Jarrow Formulas, Life Extension, NOW Foods The Bisouv Network...

The centerpiece of the Opportunity Zone (OZ) Program would get two more years of life under bipartisan legislation introduced this month in the U.S. House of Representatives. The Opportunity Zones Extension Act of 2021 would extend by two years -- until 2028 -- the ability for taxpayers to defer capital gains taxes by investing in qualified opportunity funds (QOFs).

"The Opportunity Zones Program was making a difference in East Tennessee communities and underserved areas around the country before the COVID-19 pandemic rocked our economy. Extending this program would give investors additional time to provide meaningful financial support to businesses and create quality, good-paying jobs in opportunity zones," says Rep. Tim Burchett, the Knoxville Republican who introduced the bill along with Texas Democrat Henry Cuellar.

Opportunity zones were created with bipartisan support as part of the Tax Cuts and Jobs Act of 2017 to incent investment in economically distressed areas, about 8,700 of them in areas designated by census tract across the country.

Generous deferments on capital gains invested and then realized within the QOF investments themselves have attracted billions of dollars into QOFs, although just how much is unclear.

For instance, the White House Council on Economic Advisors pegged it at $75 billion in a report last August. Burchett's news release said $52 billion before the pandemic struck. And Novogradac, the San Francisco-based consultancy that operates the Opportunity Zone Working Group (OZWG), says that 659 of the 969 QOFs it's tracking have reported dollar amount of equity they've raised and that as of year's end it was at $15.16 billion, up $3 billion since August.

"Despite unprecedented economic challenges, people continue to invest in opportunity zones," John Sciarretti, head of the OZWG and a Novogradac partner working out of its Dover, Ohio, office, says in his firm's Feb. 3 news release. "As time passes and investors become more comfortable and familiar with investing in opportunity funds, we expect the amount of investment to continue to grow."

Some stakeholders in the Opportunity Zone Program and QOFs see 2021 as the year when the program begins to gain significant traction as all that money begins to go to work, primarily in residential and commercial projects.

How this latest bill fares in Congress also will be a bellwether for the program, which provides tax breaks the likes of which were seen as possible targets by an incoming Biden administration. However, the tradeoff in economic development and job creation is seen as a win-win, and the program is gaining interest both from prominent wealth and investors more of the Main Street variety.

It would seem the OZ Program has a decent chance of continued support in Congress and the White House, although it's also safe to assume some regulatory reform will be coming, particularly in the area of reporting on the program's impact.

Perhaps the impetus to report progress as a means of justifying their existence will help push QOF managers to put that money to work sooner than later.

Read this article:

Opportunity Zone Extension Proposed in the House - Motley Fool